Merck Drops New Heart Drug Following Multaq Problems
Concerns over potential side effects similar to those encountered with the Sanofi-Aventis heart drug Multaq may have contributed to Merck & Co.’s decision to drop development of a similar heart…
Concerns over potential side effects similar to those encountered with the Sanofi-Aventis heart drug Multaq may have contributed to Merck & Co.’s decision to drop development of a similar heart…